125 related articles for article (PubMed ID: 14313483)
1. COMPLEMENT-FIXING ANTIBRAIN ANTIBODIES AND ALLERGIC ENCEPHALOMYELITIS. I. CHARACTERIZATION OF THE ANTIBODIES.
PATERSON PY; COIA EM; JACOBS AF
Ann N Y Acad Sci; 1965 Mar; 122():256-65. PubMed ID: 14313483
[No Abstract] [Full Text] [Related]
2. Suppression of allergic encephalomyelitis in rats by means of antibrain serum.
PATERSON PY; HARWIN SM
J Exp Med; 1963 May; 117(5):755-74. PubMed ID: 13941827
[TBL] [Abstract][Full Text] [Related]
3. [ON THE SEROLOGY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. I. COMPARISON OF REACTIVITY OF LIPID MIXTURES AND MYELIN EXTRACTS WITH CORRESPONDENT ANTISERA IN PRECIPITATION TESTS AND IN THE COMPLEMENT FIXATION REACTION].
NIEDIECK B; KUWERT E
Z Immunitats Allergieforsch; 1963 Dec; 125():470-92. PubMed ID: 14123283
[No Abstract] [Full Text] [Related]
4. Complement-fixing antibrain antibodies and allergic encephalomyelitis. II. Further studies concerning their protective role.
Paterson PY; Jacobs AF; Coia EM
Ann N Y Acad Sci; 1965 Jun; 124(1):292-8. PubMed ID: 5215763
[No Abstract] [Full Text] [Related]
5. Studies on acute disseminated encephalomyelitis produced experimentally in Rhesus monkeys; complement-fixing antibodies.
LUMSDEN CE; KABAT EA; WOLF A; BEZER AE
J Exp Med; 1950 Sep; 92(3):253-70. PubMed ID: 15436935
[TBL] [Abstract][Full Text] [Related]
6. The temporal relationship of complement-fixing antibrain and tuberculin type sensitivity in experimental allergic encephalomyelitis.
Greifenkamp J; Bartel AH; Fahlberg WJ
Ann Allergy; 1970 Nov; 28(11):522-7. PubMed ID: 5521183
[No Abstract] [Full Text] [Related]
7. [ON THE PATHOGENESIS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].
TSAREGORODTSEVA TM
Vestn Akad Med Nauk SSSR; 1964; 19():78-84. PubMed ID: 14198180
[No Abstract] [Full Text] [Related]
8. [ALLERGIC ENCEPHALOMYELITIS AND INTERMEDIATE ANTIGENS OF NERVE TISSUES INFECTED WITH VIRUSES].
ADO AD; KANCHURIN AKh
Sov Med; 1964 Jan; 27():56-66. PubMed ID: 14164801
[No Abstract] [Full Text] [Related]
9. [Histoserologic studies of acute experimental allergic encephalomyelitis with special reference to complement binding complexes].
Kochem HG; Kuwert E
Verh Dtsch Ges Pathol; 1967; 51():418-21. PubMed ID: 4175850
[No Abstract] [Full Text] [Related]
10. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
Hughes RA; Leibowitz S
Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
[TBL] [Abstract][Full Text] [Related]
11. FIXATION OF COMPLEMENT TO FRAGMENTS OF ANTIBODY.
REISS AM; PLESCIA OJ
Science; 1963 Aug; 141(3583):812-3. PubMed ID: 14045135
[TBL] [Abstract][Full Text] [Related]
12. Antibrain antibodies of the 19S gamma-globulin type in rats with allergic encephalomyelitis.
HARWIN SM; PATERSON PY
Nature; 1962 Apr; 194():391-2. PubMed ID: 13905113
[No Abstract] [Full Text] [Related]
13. [Immunoluminescent study of the sera of guinea pigs with experimental allergic encephalomyelitis].
Zhitnukhin IuL; Zubzhitskiĭ IuN
Biull Eksp Biol Med; 1972 Aug; 73(8):63-5. PubMed ID: 4564367
[No Abstract] [Full Text] [Related]
14. STUDIES ON MOUSE ANTIBODIES. II. MERCAPTOETHANOL-SENSITIVE 7 S ANTIBODIES IN MOUSE ANTISERA TO PROTEIN ANTIGENS.
ADLER FL
J Immunol; 1965 Jul; 95():39-47. PubMed ID: 14322578
[No Abstract] [Full Text] [Related]
15. [ON THE EFFECT OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS ON THE RETICULOENDOTHELIAL SYSTEM].
BOEHME D
Z Immunitats Allergieforsch; 1964 Mar; 126():33-5. PubMed ID: 14185403
[No Abstract] [Full Text] [Related]
16. The effects of antibrain antibodies on brain cell suspensions as determined by a cytocrit method.
Thomson JD
Life Sci; 1969 Aug; 8(16):863-9. PubMed ID: 5803380
[No Abstract] [Full Text] [Related]
17. [The pathogenesis of experimental allergic encephalomyelitis and neuritis in nerve tissue cultures (review of the literature)].
Kamzolkina NB; Kanchurin AKh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):289-94. PubMed ID: 4986495
[No Abstract] [Full Text] [Related]
18. Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats.
Paterson PY; Hanson MA
J Immunol; 1969 Oct; 103(4):795-803. PubMed ID: 5349735
[No Abstract] [Full Text] [Related]
19. IMMUNOLOGICAL CHARACTERIZATION OF VILYUISK HUMAN ENCEPHALOMYELITIS VIRUS.
CASALS J
Nature; 1963 Oct; 200():339-41. PubMed ID: 14087883
[No Abstract] [Full Text] [Related]
20. THE ROLE OF DISULFIDE BONDS IN THE COMPLEMENT-FIXING AND PRECIPITATING PROPERTIES OF 7S RABBIT AND SHEEP ANTIBODIES.
SCHUR PH; CHRISTIAN GD
J Exp Med; 1964 Oct; 120(4):531-45. PubMed ID: 14212117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
